leader in population health management, value-based care and payment, workforce development and data analytics. The Company has made an irrevocable election to present in Other Comprehensive Income subsequent changes in the fair value of this investment as this is strategic investment and is not held for trading. 5 Impairment upto March 31, 2024 is I Nil (Previous Year: I Nil). 6. NON-CURRENT TRADE RECEIVABLES Particulars As at March 31, 2024 As at March 31, 2023 Unsecured, undisputed & considered good and not due 66 39 Less : Allowance for expected credit loss (0) (0) 66 39 7. OTHER NON-CURRENT FINANCIAL ASSETS Particulars As at March 31, 2024 As at March 31, 2023 Derivative financial instruments 3,148 267 Security deposits 1,380 1,462 Lease receivables 0 19 4,528 1,748 8. DEFERRED TAX ASSETS/DEFERRED TAX LIABILITIES Particulars As at March 31, 2024 As at March 31, 2023 Deferred tax asset (net) 2,014 3,588 2,014 3,588 (I) Deferred tax assets/(liabilities) as at March 31, 2024 (i)